VIR

Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on developing immunological treatments for infectious diseases. The company uses antibody platform technologies to develop therapies for diseases including hepatitis B, influenza, HIV, and COVID-19. Vir leverages deep insights into viral immunology to create potentially transformative treatments.